Citation Impact
Citing Papers
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody
2005
Bispecific Antibodies as Targeting Agents for Boron Neutron Capture Therapy of Brain Tumors
1995
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
2000
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Treml4, an Ig Superfamily Member, Mediates Presentation of Several Antigens to T Cells In Vivo, Including Protective Immunity to HER2 Protein
2011 StandoutNobel
The implications of angiogenesis for the biology and therapy of cancer metastasis
1994 Standout
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer
1997 Standout
Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy
1994
Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
2018
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
2002
Immunospecific NMR contrast agents
1986
Boron Neutron Capture Therapy of Brain Tumors: Past History, Current Status, and Future Potential
1996
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
2005 Standout
Contrasting effects of butyrate on the expression of phenotypic markers of differentiation in neoplastic and non‐neoplastic colonic epithelial cells in vitro
1992
The rationale for prophylactic cancer vaccines and need for a paradigm shift
2006
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Present Status of Boron Neutron Capture Therapy
1992
Adenovirus Transduction and Culture Conditions Affect the Immunogenicity of Murine Dendritic Cells
2005
An Immunohistochemical Study of Architectural Remodeling and Connective Tissue Synthesis in Pulmonary Fibrosis
1989
Conjugation of phenyl isothiocyanate derivatives of carborane to antitumor antibody and in vivo localization of conjugates in nude mice
1991
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Interleukin-6 in Biology and Medicine
1993
Imaging in the era of molecular oncology
2008 StandoutNature
New approaches to antibody therapy
2000
Cancer Statistics, 2006
2006 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Pancreatic cancer
2016 Standout
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Expression of an antibody Fv fragment in myeloma cells
1988 StandoutNobel
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Diagnosis of gastric cancers with fluorescein‐labeled monoclonal antibodies to carcinoembryonic antigen
1989
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy
1988
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
2009
Cancer vaccines: between the idea and the reality
2003
Calmodulin as a Versatile Tag for Antibody Fragments
1995 StandoutNobel
The DNA damage response, immunity and cancer
2006
Carboranyl peptide-antibody conjugates for neutron-capture therapy: preparation, characterization, and in vivo evaluation
1992
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Gut flora in health and disease
2003 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
1995 Standout
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
1993 Science
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Review of clinical radioimmunotherapy
2006
Novel carboranyl amino acids and peptides: reagents for antibody modification and subsequent neutron-capture studies
1991
Tumor Angiogenesis
2008 Standout
Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy
1994
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
2007 StandoutNobel
Neutron-capture therapy of human cancer: in vitro results on the preparation of boron-labeled antibodies to carcinoembryonic antigen.
1982
Challenges and Opportunities for the Application of Boron Clusters in Drug Design
2016
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Molecular recognition in antibodies and its application
1991
Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood.
1990
Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.
1994
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
1983 Standout
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Applications of Radiolabeled Boron Clusters to the Diagnosis and Treatment of Cancer
1999
Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model
1991
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
2007
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Design by Directed Evolution
1998 StandoutNobel
Three Different Vaccines Based on the 140-Amino Acid MUC1 Peptide with Seven Tandemly Repeated Tumor-Specific Epitopes Elicit Distinct Immune Effector Mechanisms in Wild-Type Versus MUC1-Transgenic Mice with Different Potential for Tumor Rejection
2001
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer
1993 Standout
The effect of particle design on cellular internalization pathways
2008 Standout
Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.
1986
Randomized phase II /III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS ‐PC Study
2015
Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.
1986
About Dendrimers: Structure, Physical Properties, and Applications
1999 Standout
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
1991
Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
1999
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
The biology of cancer metastasis and implications for therapy
1987
TARGETED CONTRAST AGENTS IN MR IMAGING
1996
The Chemistry of Neutron Capture Therapy
1998 Standout
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Molecular Dynamics of Ion−Chelate Complexes Attached to Dendrimers
1996 StandoutNobel
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
2019 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Boron neutron capture therapy for cancer. Realities and prospects
1992
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Differential Reactivities of Carcinoembryonic Antigen (CEA) and CEA-Related Monoclonal and Polyclonal Antibodies in Common Epithelial Malignancies
1990
PET imaging of (86)Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between (86)Y and (111)In radiolabels.
2001
Multiple biochemical markers in patients with gynecologic malignancies
1980
The chemistry of boron analogues of biomolecules
1994
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses
2004
Dendrimers in Oncology: An Expanding Horizon
2008
Gene-based vaccines: recent technical and clinical advances
2006
Therapeutic implications of patterns of recurrence in cancer of the uterine cervix
1979
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Surface molecular recognition
2001 StandoutNobel
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of F. James Primus being referenced
Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen
2000
Synthesis and Characterization of Oligomeric nido-Carboranyl Phosphate Diester Conjugates to Antibody and Antibody Fragments for Potential Use in Boron Neutron Capture Therapy of Solid Tumors
1994
Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells
1991
An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice
2001
Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy.
1998
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein
1980
Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.
2001
Rationale for Antiangiogenic Cancer Therapy with Vaccination Using Epitope Peptides Derived from Human Vascular Endothelial Growth Factor Receptor 2
2005
Preparation and properties of nido-carborane-specific monoclonal antibodies for potential use in boron neutron capture therapy for cancer.
1995
Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
2000
Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen.
1973
Site‐specific linkage of methotrexate to monoclonal antibodies using an intermediate carrier
1988
Neutron-capture therapy of human cancer: in vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in the GW-39 tumor model system.
1984
Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning
1978
Immunoperoxidase Localization of Carcinoembryonic Antigen in Normal Human Intestinal Mucosa<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>
1981
Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens
1978
Altered metabolism of carcinoembryonic antigen in hamsters bearing GW-39 tumours
1974 Nature
Detection of carcinoembryonic antigen in tissue sections by immunoperoxidase
1975
A Dual-Function DNA Vaccine Encoding Carcinoembryonic Antigen and CD40 Ligand Trimer Induces T Cell-Mediated Protective Immunity Against Colon Cancer in Carcinoembryonic Antigen-Transgenic Mice
2001
Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model.
1988
Carcinoembryonic Antigen in Histopathology: Immunoperoxidase Staining of Conventional Tissue Sections2
1976
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
1998
Dendritic Cells Pulsed with an Anti-Idiotype Antibody Mimicking Carcinoembryonic Antigen (CEA) Can Reverse Immunological Tolerance to CEA and Induce Antitumor Immunity in CEA Transgenic Mice
2004
DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor
2005
Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen.
1980
An unlabeled antibody method using glucose oxidase-antiglucose oxidase complexes (GAG): a sensitive alternative to immunoperoxidase for the detection of tissue antigens.
1982
Differential Expression of Tumor-Associated Antigens in Human Colon Carcinomas Xenografted Into Nude Mice<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>
1983
Bispecific Antibody Mediated Targeting of nido-Carboranes to Human Colon Carcinoma Cells
1996
Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen.
1987
Carcinoembryonic antigen in carcinoma of the uterine cervix2. Tissue localization and correlation with plasma antigen concentration
1979